ProImmune Cash, 31-Dec-2018274.6 K

ProImmune Funding

Summary Metrics

Founding Date

2000

ProImmune Balance Sheet

Annual

GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

438.4k413.9k426.1k278.9k274.6k

Accounts Receivable

476.3k141.6k144.6k165.7k185.1k

Current Assets

4.2m6.6m11.9m15.0m17.1m

PP&E

111.9k129.7k132.4k197.1k147.4k

Total Assets

4.5m6.9m12.2m15.4m17.4m

Accounts Payable

339.4k88.5k185.1k328.5k156.8k

Current Liabilities

339.4k309.0k555.1k532.9k553.1k

Non-Current Liabilities

13.1k10.1k456.1k603.5k423.1k

Total Liabilities

352.5k319.1k1.0m1.1m976.2k

Common Stock

2.0k2.0k2.0k2.0k2.0k

Retained Earnings

4.1m6.5m11.1m14.2m16.4m

Total Equity

4.1m6.5m11.1m14.2m16.4m

Financial Leverage

1.1 x1 x1.1 x1.1 x1.1 x

ProImmune Ratios

FY, 2014

Financial Leverage

1.1 x

ProImmune Operating Metrics

ProImmune's Customers was reported to be 500 in Oct, 2018.
Oct, 2018

Customers

500